Background
Polyomavirus nephropathy (PVAN) is a common cause of kidney allograft dysfunction and loss. To identify PVAN-specific gene expression and underlying molecular mechanisms we analyzed kidney biopsies with and without PVAN.
Methods
The study included 168 posttransplant renal allograft biopsies (T cell mediated rejection=26, PVAN=10, normal functioning graft (STA) =73, and interstitial fibrosis/tubular atrophy (IF/TA) =59) from 168 unique kidney allograft recipients. We performed gene expression assays and bioinformatics analysis to identify a set of PVAN-specific genes. Validity and relevance of a subset of these genes are validated by QPCR and IHC.
Results
Unsupervised hierarchical clustering analysis of all the biopsies revealed high similarity between PVAN and TCMR gene expression. Increased statistical stringency identified 158 and 252 unique PVAN and TCMR injury-specific gene transcripts respectively. While TCMR-specific genes were overwhelmingly involved in immune response costimulation and TCR signaling, PVAN-specific genes were mainly related to DNA replication process, RNA polymerase assembly and pathogen recognition receptors. A principal component analysis using these genes further confirmed the most optimal separation between the 3 different clinical phenotypes. Validation of 4 PVAN-specific genes (RPS15, CFD, LTF, and NOSIP) by QPCR and confirmation by immunohistochemistry of 2 PVAN-specific proteins with anti-viral function (LTF and IFITM1) was done.
Conclusions
In conclusion, even though PVAN and TCMR kidney allografts share great similarities on gene perturbation, PVAN-specific genes were identified with well-known anti-viral properties that provide tools for discerning PVAN and AR as well as attractive targets for rational drug design.